Income Statement (SANOFI/NV)

SANOFI/NV NEWS

P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials By Site Author - 1 week ago

Contributors: DG, FG, and MV conceived and designed the study. DG, FG, HW, JK, AAP, and MV transferred and validated the original data. DG, FG, and MV combined, managed, analysed, and output the data… [+6981 chars]...

Read more
Ablynx (OTCMKTS:ABLYF) & Calidi Biotherapeutics (NYSE:CLDI) Head-To-Head Survey By MarketBeat - 1 week ago

Ablynx (OTCMKTS:ABLYF – Get Free Report) and Calidi Biotherapeutics (NYSE:CLDI – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ba… [+5689 chars]...

Read more
Reviewing Ablynx (OTCMKTS:ABLYF) and Replimune Group (NASDAQ:REPL) By MarketBeat - 2 weeks ago

Replimune Group (NASDAQ:REPL – Get Free Report) and Ablynx (OTCMKTS:ABLYF – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on … [+5663 chars]...

Read more
Messenger RNA Market Research Report 2025-2035, Competitive Analysis of Pfizer, GSK, Arcturus Therapeutics, AstraZeneca, Beam Therapeutics, Moderna, Oncotelic, SK Bioscience, Sangamo, Sanofi CureVac By Research - 6 days ago

Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Focus on Application and Regional Analysis - Analysis and Forecast, 2025-2035" report has been ad… [+7119 chars]...

Read more
AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors By Rose - 5 days ago

  • US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industry
  • The appointment comes as Ast… [+4641 chars]...

    Read more
Top Stock
CurrencyPrice Chg
BA
200.26 -1.44
-0.71%
CVX
148.85 2.82
1.93%
CAT
357.68 -4.76
-1.31%
INTC
20.79 0.05
0.24%
MSFT
478.04 -1.1
-0.23%
DIS
118.13 -1.35
-1.13%
DOW
29.44 -1.13
-3.7%
CSCO
65.34 -0.17
-0.26%
GS
624.64 -3.21
-0.51%